ConductScience.org, home

Gene · 23089

PEG10: paternally expressed 10

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. PEG10: paternally expressed 10. Genes, record 23089. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23089

On this page

Gene

Symbol
PEG10
HGNC
Name
paternally expressed 10
HGNC
NCBI Gene ID
23089
NCBI Gene
HGNC ID
HGNC:14005
HGNC
Ensembl
ENSG00000242265
NCBI Gene
Aliases
EDR, HB-1, KIAA1051, MEF3L, Mar2, Mart2, RGAG3, RTL2, SIRH1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q86TG7Retrotransposon-derived protein PEG107081Ensembl, GeneID, HGNC

Source UniProt

Patents11

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2025517657 A2025-06-1022Q86TG7Espacenet
WO 2025097132 A12025-05-0870Q86TG7Espacenet
JP 2022147356 A2022-10-06220Q86TG7Espacenet
JP 2022517803 A2022-03-108Q86TG7Espacenet
WO 2020148310 A12020-07-236Q86TG7Espacenet
JP 2020062004 A2020-04-231425Q86TG7Espacenet
US 10533225 B22020-01-14123Q86TG7Espacenet
EP 3258268 A12017-12-20185Q86TG7Espacenet
US 9677138 B22017-06-13123Q86TG7Espacenet
WO 2016103269 A12016-06-302903Q86TG7Espacenet

1 to 10 of 11

See all 11 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants820

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitlePEG10 papersNewest fiscal year
P30ES025128Center for Human Health and the Environment (CHHE)92025
P30CA008748Cancer Center Support Grant82025
P30CA016672Cancer Center Support Grant62025
P30ES017885Michigan Center on Lifestage Environmental Exposures and Disease (M-LEEaD)62025
P30CA125123Baylor College of Medicine Cancer Center - Cancer Center Support Grant42025
P30CA016086Cancer Center Support Grant32025
P30CA060553The Robert H. Lurie Comprehensive Cancer Center32025
P50CA097186The Pacific Northwest Prostate Cancer SPORE32025
P01AG019724Frontotemporal Dementia: Genes, Images, and Emotions22025
P01AI120943Molecular Mechanisms of Filoviral-host Interactions22025

1 to 10 of 820Source NIH's project files

See all 820 nih grants

Papers1,379

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Placenta-Related PEG10 Inhibits mRNA Decay to Promote Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.Cancer Res202642826094PubTator, text miningPubMed
Structure-guided antisense oligonucleotides selectively modulate frameshifting of a human gene.bioRxiv202642818233PubTator, text miningPubMed
MicroRNA-122 as a regulator and biomarker of liver disease.J Mol Med (Berl)202642760391PubTator, text miningPubMed
Well-established efficacy of camrelizumab combined with radiofrequency ablation in cirrhotic patients with hepatic cancer.Am J Transl Res202642631165PubTator, text miningPubMed
Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells.Front Oncol202642568401PubTator, text miningPubMed
Non-Cytopathic Mammalian Orthoreovirus Infection Triggers Innate Immune Responses in Human Tonsil-Derived Mesenchymal Stem Cells: Implications for Cell Therapy Quality Control.Tissue Eng Regen Med202642467368PubTator, text miningPubMed
Membrane bionic supramolecular nanomaterials for co-delivered of ribociclib and PEG10 siRNA for targeted therapy in breast cancer.Cancer Lett202642457019PubTator, text miningPubMed
Integrative transcriptomic and CRISPR dependency analysis identifies hepatoblastoma-specific essential genes and actionable vulnerabilities.Cancer Genet202642385356PubTator, text miningPubMed
Hypoxia and lactate metabolism-related gene COL5A3 promotes triple negative breast cancer progression via DDR1/FAK/PI3K/AKT pathway.Biol Direct202642310796PubTator, text miningPubMed
Engineering human PEG10-based nanoparticles for RNA self-packaging, delivery and cancer therapy.Nat Commun202642285982PubTator, text miningPubMed

1 to 10 of 1,379

See all 1,379 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/23089

GET https://conductscience.org/api/genes/v1/23089/patents